IRIS
PIRAS, Sandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.079
AS - Asia 2.664
SA - Sud America 1.855
EU - Europa 1.753
AF - Africa 118
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 10
Totale 32.491
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.948
BR - Brasile 1.653
SG - Singapore 1.106
CN - Cina 772
UA - Ucraina 486
IT - Italia 440
HK - Hong Kong 259
DE - Germania 235
SE - Svezia 143
VN - Vietnam 109
FI - Finlandia 98
GB - Regno Unito 91
AR - Argentina 88
TR - Turchia 66
IN - India 55
CA - Canada 53
RU - Federazione Russa 51
BD - Bangladesh 44
MX - Messico 42
BE - Belgio 35
FR - Francia 35
IQ - Iraq 33
ZA - Sudafrica 33
EC - Ecuador 28
PK - Pakistan 28
CO - Colombia 25
KR - Corea 25
MA - Marocco 24
NL - Olanda 24
PL - Polonia 23
UZ - Uzbekistan 22
JP - Giappone 21
VE - Venezuela 19
KE - Kenya 18
CZ - Repubblica Ceca 16
AE - Emirati Arabi Uniti 15
IR - Iran 15
JO - Giordania 15
PY - Paraguay 13
ID - Indonesia 11
NP - Nepal 11
IE - Irlanda 10
AU - Australia 9
DZ - Algeria 9
EG - Egitto 9
ES - Italia 9
LT - Lituania 9
PE - Perù 9
SA - Arabia Saudita 9
AZ - Azerbaigian 8
CL - Cile 8
AT - Austria 7
BG - Bulgaria 7
JM - Giamaica 7
KZ - Kazakistan 7
OM - Oman 7
PA - Panama 7
TN - Tunisia 7
EU - Europa 6
IL - Israele 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
RO - Romania 5
RS - Serbia 5
TT - Trinidad e Tobago 5
AL - Albania 4
BO - Bolivia 4
CI - Costa d'Avorio 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
KG - Kirghizistan 3
NG - Nigeria 3
NI - Nicaragua 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
GY - Guiana 2
HN - Honduras 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
PS - Palestinian Territory 2
SM - San Marino 2
AM - Armenia 1
BH - Bahrain 1
CH - Svizzera 1
CU - Cuba 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
HR - Croazia 1
HU - Ungheria 1
Totale 32.477
Salva come PNG Salva come JPEG
Città #
Dallas 22.923
Chandler 631
Singapore 587
Jacksonville 287
Hong Kong 252
Ashburn 213
Beijing 177
Princeton 176
New York 160
Nanjing 131
São Paulo 114
Dearborn 107
Ann Arbor 92
Sassari 86
Wilmington 69
Los Angeles 65
Belo Horizonte 55
Nanchang 55
Shanghai 55
Rio de Janeiro 50
Boardman 49
Ho Chi Minh City 48
Munich 35
Santa Clara 35
Brasília 32
Brussels 30
Woodbridge 30
Shenyang 28
Changsha 27
Tianjin 26
Hebei 25
Seoul 25
Buenos Aires 24
Campinas 24
Mountain View 24
Cagliari 23
Johannesburg 23
Denver 22
Jinan 22
Baghdad 21
Helsinki 21
Jiaxing 21
Montreal 21
Rome 21
Tashkent 21
Warsaw 21
Curitiba 20
Porto Alegre 20
The Dalles 20
Tokyo 20
Hanoi 19
Council Bluffs 18
Salvador 18
San Francisco 18
Chennai 17
Brooklyn 16
Buffalo 16
Chicago 16
Columbus 16
Goiânia 16
London 16
Milan 16
Santo André 16
Andover 15
Nairobi 15
Poplar 15
Toronto 15
Boston 14
Brno 14
Izmir 14
Amman 13
Dhaka 13
Guangzhou 13
Manaus 13
Mexico City 13
Mumbai 13
Atlanta 12
Haikou 12
Asunción 11
Augusta 11
Orem 11
Betim 10
Caxias do Sul 10
Dublin 10
Frankfurt am Main 10
Naples 10
Ribeirão Preto 10
Sorocaba 10
Stockholm 10
São José dos Campos 10
West Jordan 10
Barbianello 9
Bogotá 9
Carapicuíba 9
Casablanca 9
Feira de Santana 9
Franca 9
Guarulhos 9
Houston 9
Istanbul 9
Totale 27.700
Salva come PNG Salva come JPEG
Nome #
[1,2,3]triazolo[4,5-H]chinoloni: una nuova classe di promettenti chemioterapici antitubercolari 10.301
[1,2,3]triazolo[4,5-H]chinoloni: una nuova classe di promettenti chemioterapici antitubercolari 10.256
Synthesis of Novel Tricyclic N-Acylhydrazones as Tubulin Polymerization Inhibitors 444
Nuovi derivati chinossalinici inibitori della Diidrofolato Reduttasi (DHFR) e della Timidilato Sintetasi (TS) dellaLeishmania major: risultati preliminari 291
Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor Activity 272
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 230
Design, synthesis and antileukemia evaluation of Imatinib-like compounds as BCR-ABL1 protein kinase inhibitors 223
Design and synthesis of novel FGFR inhibitors for the treatment of glioblastoma 221
1H,6H-triazolo[4,5-e]benzotriazole-3-oxides and 5,5’-(Z)-diazene-1,2-diylbis(2-methyl-2H-1,2,3-benzotriazole) derived from chloronitrobenzotriazoles and hydrazine 220
2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7trifluoromethylquinoxalines as anticancer agents Inhibitors of folate enzymes 206
Benzotriazole: an overview on its versatile biological behaviour 204
A comprehensive assessment of a new series of 5′,6′-difluorobenzotriazole-acrylonitrile derivatives as microtubule targeting agents (MTAs) 178
A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems 175
Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase 170
5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus 166
Enhancement of antimicrobial activity of pump inhibitors associating drugs 166
Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives 162
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: A novel classo f potent tubulin inhibitors 159
Anti-mycobacterial activity of quinolones. Triazoloquinolones a new class of potent anti mycobacterial agents 150
Design, Synthesis, and Antiviral Activities of New Benzotriazole-Based Derivatives 143
2(3)-Aryl-thio(oxy)-methylquinoxaline Derivatives: A New Class of P-Glycoprotein-Mediated Drug Efflux Inhibitors 143
Anti-BVDV Activity Evaluation of Naphthoimidazole Derivatives Compared with Parental Imidazoquinoline Compounds 143
4,7-FENANTROLINE: UNA NUOVA CLASSE DI INIBITORI DELLA POLIMERASI DI RNA-VIRUS 141
Design, synthesis, and biological screening of a series of 4′-fluoro-benzotriazole-acrylonitrile derivatives as microtubule-destabilising agents (MDAs) 140
Antiviral activities of 5-chlorobenzotriazole derivatives 137
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development 133
Antibiotics and Carbohydrate-Containing Drugs Targeting Bacterial Cell Envelopes: An Overview 132
Synthesis of 2-(Quinoxalin-2-ylamino-benzotriazolyl) Pentanedioic Derivatives as Potential Anti-Folate Agents 132
Development of folates analogs against folate-dependent enzymes 131
Synthesis and anti-mycobacterial activities of triazoloquinolones 130
Inhibition of Enterovirus A71 by a Novel 2-Phenyl-Benzimidazole Derivative 129
E-3-aril-(1H-benzotriazol-1-il)acrilonitrili: una nuova classe di inibitori della tubulina ad attività antitumorale 128
Manuale di analisi farmaceutica. Analisi organica qualitativa non strumentale 127
Synthesis and antiviral activity of new phenylimidazopyridines and N-benzylidenequinolinamines derived by molecular simplification of phenylimidazo[4,5-g]quinolines 127
Preliminary anti-coxsackie activity of novel 1-[4-(5,6-dimethyl(h)1h(2h)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas 123
Quinoline tricyclic derivatives. Design, synthesis and preliminary in vitro and in silico antiviral activity against flaviridae family of three new classes of virus encoded RNA- dependent polymerase(RdRp). In: Book of Abstracts 123
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. . 122
Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells 121
Antiviral activity of benzotriazole based derivatives 120
Solid Lipid Nanoparticles as Formulative Strategy to Increase Oral Permeation of a Molecule Active in Multidrug-Resistant Tuberculosis Management 120
Quinoxaline chemistry.Part 6 Synthesis and evaluation of antiulcer and gastroproctetive activity of 2-[arylmethylmercapto-,arylmethylsulfinyl-,piperazinyl-3-R-substituted]quinoxalines 118
Activity and molecular modeling of a new small molecule active against NNRTI-resistant HIV-1 mutants 116
SAR and Anti-Mycobacterial Activity of Quinolones and Triazoloquinolones: An Update 115
Analisi Qualitativa Farmaceutica 115
Development of oxygen-bridged pyrazole-based structures as cannabinoid receptor 1 ligands 114
Inhibition of RNA Helicase of ssRNA+ virus belonging to Flaviviridae, Coronaviridae and Picornaviridae families 112
Improving in vivo oral bioavailability of a poorly soluble drug: a case study on polymeric versus lipid nanoparticles 110
Novel N-aryl nicotinamide derivatives: tacking stock on 3,6-diazabicyclo[3.3.1]heptanes as ligands for neuronal acetylcholine receptors 108
Benzimidazole-2-Phenyl-Carboxamides as Dual-Target Inhibitors of BVDV Entry and Replication 107
Quinoxaline chemistry. Part 6- Synthesis and evaluation of antiulcer and gastroprotective activity of 2 –[arylmethylmercapto- arylmethylsulfinyl- piperazinyl- 3- r- substitute] quinoxalines. 107
Synthesis, Antitumor and Antiviral In Vitro Activities of New Benzotriazole-Dicarboxamide Derivatives 106
Reaction of 5-aminobenzotriazoles with methyl propiolate. Formation of triazolo[4,5-f]quinolines and related compounds. Unusual products in the Michael addition reaction of 2-methyl-2H-5-aminobenzotriazole 106
Quinoxaline derivatives as new inhibitors of coxsackievirus B5 105
Triazolopyridinyl-acrylonitrile derivatives as antimicrotubule agents: synthesis, in vitro and in silico characterization of antiproliferative activity, inhibition of tubulin polymerization and binding thermodynamics 104
Benzoyl-piperazinil chinossaline come potenziali antitumorali 102
Dichloro-phenyl -benzotriazoles: a new selective class of human respiratory syncytial virus entry inhibitors 102
Quinoxaline chemistry. Part 15.4-[2-quinoxalylmethylenimino]-benzoylglutamates and benzoates, 4-[2-quinoxalylmethyl-N-methylamino]-benzoylglutamates as analogues of classical antifolate agents. Synthesis, elucidation of structures and in vitro evaluation of antifolate and anticancer activities 101
Phytochemical compositions and biological activities of essential oils from the leaves, rhizomes and whole plant of hornstedtia bella Škorničk 101
Synthesis and anti-picornaviridae in vitro activity of a new class of helicase inhibitors the N,N'-bis[4-(1H(2H)-benzotriazol-1(2)-yl)fenyl]alkyldicarboxamides 100
Reactions Of Alkylation Of Biologically Interesting Triazolo[4,5-g]Quinolines And Triazolo[4,5-g]Quinoline-1-Oxides With Electrophilic Reagents 99
Synthesis and evaluation of gastroprotective activity of omeprazole related benzimidazole, imidazo(4,5-b)pyridine and quinoxaline 2-substituted derivatives 97
Quinoxaline Chemistry. Part 17. 4[3,6(7) disubstituted-2-quinoxalinyl-oxa]phenylacetate and phenylacetylglutamate analogues of methotrexate: Synthesis and evaluation of in vitro anticancer activity 96
Human Enterovirus B: Selective Inhibition by Quinoxaline Derivatives and Bioinformatic RNA-Motif Identification as New Targets 95
Analisi Farmaceutica Qualitativa 93
Manuale di analisi qualitativa. Con e-book. EDISES 93
quinoxaline chemistry.Part 7. 2-[aminobenzoates]-and2-[aminobenzoylglutamate]-quinoxalines as classical antifolate agents. Sinthesis and evaluation of in vitro anticancer, anti- HIV and antifungal activity 92
Synthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides 92
Quinoxaline analogues-homologues of methotrexate 91
Benzotriazolilfenilalchilammidi. Una nuova classe di inibitori delle RNA elicasi di virus a singola catena a RNA a genoma positivo e negativo 90
Chemistry, biological properties and SAR analysis of quinoxalinones 89
Synthesis and evaluation of gastroprotective and antiulcer of some 2-substituted- 1H- imidazo[4,5-b]pyridines and 1H- benzimidazoles. 89
Ligand-based virtual screening and ADME-tox guided approach to identify triazolo-quinoxalines as folate cycle inhibitors 89
Quinoxaline chemistry. Part 14. 4-(2-quinoxalylamino)-phenylacetates and 4-(2-quinoxalylamino)-phenylacetyl-L-glutamates as analogues-homologues of classical antifolate agents. Synthesis and evaluation of in vitro anticancer activity 87
Synthesis and biological evaluation of novel indole-derived thioureas 87
Synthesis and evaluation of gastroprotective and antiulcer activity of some 2- substituted-1H-imidazo[4,5-b] pyridines and -1H-benzimidazoles 87
Chasing the evaders. Design, Synthesis, Activity, and Molecular Modeling of a New Small Molecule with Activity Against Drug-Resistant HIV-1 mutants 86
Sinthesis and evaluation of gastroproctetive activity of omeprazole related benzimidazole,imidazo[4,5-b]pyridine and quinoxaline 2-substituted derivatives 85
Sintesi di nuove 6,7-diamminochinoline quali intermedi per la preparazione di molecole ad attività biologica 85
Novel 3-benzoyl-2-piperazinylquinoxaline derivatives as potential antitumor agents 85
New Imatinib-like compounds as Bcr-Abl1 protein kinase inhibitors: design, synthesis and antileukemia evaluation 83
Quinoline triciclic derivatives. Design, synthesis and preliminary in vitro and in silico antiviral activity against flaviviridae family of three new classes of viruses-encoded RNA-dependent RNA polymerase (RdRp) inhibitors 83
Triazolochinoloni. Una nuova classe di agenti antitubercolari attivi su ceppi MDR di M. tuberculosis 79
Synthesis and in vitro evaluation of the antiviral activity of a series of novel N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides 77
Quinoline tricyclic derivatives. Design, synthesis and evaluation of the antiviral activity of three new classes of RNA-Dependent RNA Polymerase inhibitors 77
Discovery of pyridoquinoxaline-based new P-gp inhibitors as coadjutant against Multi Drug Resistance in cancer 74
Synthesis of linear azolo and pyrido quinolines from quinoline derivatives 73
Synthesis and evaluation of antiulcer and gastroprotective activity of 2-[arylmethylmercapto-, arylmethylsulfinyl-, piperazinyl-3-r-substituted] quinoxalines 72
Synthesis and in vitro anticancer evaluatio of variously substituted 3- phenoxymethyl quinoxalin-2-ones and quinoxalines in combination with various drugs against kb mdr tumor cells 71
Systhesis and evaluation of gastroprotective activity of omeprazole imidazo(4,5-b) pyridine and quinoxaline 2- substituted derivatives. 70
E-3-aril-2-(1H-benzotriazol-1-il)acrilonitrili: una nuova classe di inibitori della tubulina ad attività antitumorale 70
Quinoline tricyclic derivatives. Design, synthesis and preliminary in vitro and in silico antiviral activity against flaviviridae family of three new classes of virus-encoded RNA-dependent RNA polymerase (RdRp) inhibitors 68
Sintesi di nuove 6,7- diamminochinoline quali intermedi per la preparazione di molecole ad attività biologica 67
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development 66
Helicase inhibitors as anti-RNA virus agents 66
Novel quinoxaline analogues as inhibitors of folate enzimes 65
Sintesi di una nuova serie di N-[4-(1H(2H)-benzotriazol-1(2)-il)fenil]alchilcarbossiammidi e N,N'-bis[4-(1H(2H)-benzotriazol-1(2)-il)fenil]alchildicarbossiammidi a potenziale attività antivirale 65
Sintesi di una nuova serie di n-[4-(1H(2H)-benzotriazol-1(2)- il)fenil]alchilcarbossiammidi e n,n'-bis[4-(1H(2H)-benzotriazol- 1(2)-il)fenil]alchildicarbossiammidi a potenziale attività antivirale 64
nuovi derivari chinossalinici inibitori della diidrofolato reduttasi (DHFR) e della timidilato sintetasi (TS) della leishmania major: risultati preliminari 63
Quinoxaline analogues-homologues of classical antifolates 61
Sintesi ed attività antiulcera di 2-arilmetilmercapto-, 2-solfinilarilchinossaline 61
Totale 32.270
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.728
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021408 0 0 0 0 0 26 87 16 96 98 69 16
2021/2022501 67 2 5 12 6 11 16 30 51 51 61 189
2022/20231.232 105 101 31 206 98 193 14 157 198 20 66 43
2023/2024510 56 24 17 12 76 122 10 30 1 19 59 84
2024/20253.398 29 33 155 111 101 72 277 653 1.097 567 189 114
2025/202625.009 332 6.419 16.603 1.076 507 72 0 0 0 0 0 0
Totale 32.592